Welcome to our dedicated page for Healthequity SEC filings (Ticker: HQY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HealthEquity, Inc. filings document regulatory disclosures for an HSA custodian and consumer-directed benefits administrator. Recent 8-K reports cover operating results and financial condition, guidance furnished under Regulation FD, HSA account and asset metrics, revenue categories, stock repurchase activity, and hedging used to reduce HSA cash repricing risk.
Governance filings record board appointments and committee assignments, annual meeting vote results, auditor ratification, advisory executive compensation votes, executive employment agreement amendments, severance arrangements, equity award terms, and technology-organization leadership responsibility. These disclosures frame the company's capital allocation, compensation governance, risk oversight and public-company reporting obligations.
HealthEquity, Inc. (HQY) filed a Form 144 proposing sale of 3,461 common shares valued at $322,915.80, to be sold on 09/05/2025 on NASDAQ. The filing shows the shares were acquired and paid for on 09/05/2025 through a stock option exercise from the issuer and paid in cash. The filer reports 86,156,334 shares outstanding, so the proposed sale represents a very small portion of the company’s outstanding common stock. The filer certifies they are not aware of any undisclosed material adverse information.
HealthEquity reported continued scale in its HSA business and active capital and risk management steps. The company administered 10.0 million HSAs with $33.1 billion of HSA Assets and 17.1 million total accounts. It completed the BenefitWallet HSA portfolio acquisition for $425.0 million, financed in part with $225.0 million of borrowings under its revolving credit facility. Deferred revenue was $11.5 million versus $17.1 million at year-end. The company uses Treasury bond forwards as cash-flow hedges to manage interest-rate exposure on expected transitions of HSA cash. Net income for the six months rose 76% year-over-year, driven by higher gross profit and lower operating expenses. Revolving credit outstanding was $411.9 million and the 4.50% senior notes fair value was $578.9 million. Management expects existing liquidity and the credit facility to be sufficient for at least the next 12 months.
HealthEquity, Inc. furnished a press release to the SEC as an exhibit to a Form 8-K; the press release is attached as Exhibit 99.1 and the company specifies the exhibit is being furnished rather than filed, so it is not subject to Section 18 liabilities and is not incorporated by reference into other filings unless explicitly stated. The Form 8-K lists the furnishing of the exhibit under the exhibits section and does not include financial statements, earnings data, or other substantive disclosures within the filing text provided here.